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Proteoglycan 4 (PRG4), also known as lubricin1 and superﬁcial
zone protein2, is a mucinous glycoprotein that is present in synovial
ﬂuid (SF) and at the surface of articular cartilage, where it functions
as a critical boundary lubricant necessary for joint health3. High
friction and high wear are amongst many factors that may
contribute to cartilage degeneration4. PRG4 is critical in reducing
friction and minimising surface tissue shear5 at the surface of
cartilage, thus preventing the degradation of cartilage through
boundary lubrication. Indeed, an increased coefﬁcient of friction in
PRG4-knockout mice is associated with increased wear of the
articular surface6. Furthermore, intra-articular injection of PRG4 has
been shown to prevent cartilage degradation in post-injury rat
models of osteoarthritis (OA)7. A recent study, motivated by
diminished PRG4 levels in SF associated with early OA, demon-
strated aldehyde modiﬁcation of PRG4 (PRG4-CHO) signiﬁcantly
enhanced its binding to a depleted articular surface8. Such modiﬁ-
cation may contribute to an improved biotherapeutic treatment of
early OA with PRG4 through enhanced residence time within the
joint and/or binding to the articular cartilage surface. However, it
remains to be determined if PRG4-CHO maintains the friction-
reducing ability of unmodiﬁed PRG4. Therefore, the objective ofT.A. Schmidt, 2500 University
2N 1N4, Canada. Tel: 1-403-
t).
s Research Society International. Pthis study was to assess the cartilage boundary lubricating ability of
PRG4-CHO vs unmodiﬁed PRG4 using a previously described in vitro
cartilageecartilage friction test5,9. Theﬁndings of this study indicate
that aldehyde modiﬁcation does not signiﬁcantly affect the protein
structure or lubricating function of PRG4, and PRG4-CHO is an
effective friction reducing cartilage boundary lubricant. These
results, together with previously published data8, collectively
suggest PRG4-CHOmaybeuseful inmolecular resurfacing strategies
for tissue surfaces requiring lubrication, and potentially other bio-
interfaces or biomaterials as well.
Methods
Lubricant preparation and characterisation
PRG4
PRG4 was prepared from bovine cartilage, as described previ-
ously5. Brieﬂy, cartilage discs with an intact articular surface were
harvested from fresh skeletally mature bovine stiﬂe joints (Calgary,
AB, Canada) and were cultured for 28 days in the presence of trans-
forming growth factor-b15. PRG4 was puriﬁed from the conditioned
media using Diethylaminoethyl (DEAE) anion exchange chromatog-
raphy and centrifugal ﬁltration5. Purity was conﬁrmed using 3e8%
Tris-Acetate Sodium Dodecyl Sulfate Polyacrylamide Gel Electro-
phoresis (SDS-PAGE) followed by protein stain or western blotting
using Invitrogen’s NuPAGE system (Carlsbad, CA, USA), described
below. The concentrationwas then determined by bicinchoninic acid
assay (BCA) (Thermo Fisher Scientiﬁc; Rockford, IL, USA).ublished by Elsevier Ltd. All rights reserved.
Fig. 1. Protein stain of non-reduced (NR) and reduced (R) (A, B), and western blotting
of NR (C) and R (D) PRG4 samples.
S. Abubacker et al. / Osteoarthritis and Cartilage 21 (2013) 186e189 187Aldehyde Modiﬁed PRG4 (PRG4-CHO)
Aldehyde modiﬁed PRG4 (PRG4-CHO) was prepared from
immature bovine stiﬂe joints as described previously5,8. Brieﬂy,
PRG4-CHO was prepared using succinimidyl-4-formylbenzamide
(CHO) at a PRG4:CHO molar ratio of 1:100 in 100 mM PO4 buffer7.
A treatment control (PRG4-SHAM) was exposed to modiﬁcation
buffers and incubations in the absence of CHO. Conﬁrmation of
PRG4 purity and the CHO reaction was assessed by SDS-PAGE,
describe below, and followed by quantiﬁcation by BCA.
SDS-PAGE
SDS-PAGE analysis was used to characterise the size distribu-
tions and immunoreactivity of species in PRG4, PRG4-SHAM, and
PRG4-CHO. Brieﬂy, non-reduced (NR) and reduced (R) samples
were subject to 3e8% SDS-PAGE followed by protein stain and/or
western blotting using anti-PRG4 antibodies LPN and J108N for NR
and R, respectively, as described previously10e12.
Boundary lubrication tests
Osteochondral sample preparation
Fresh osteochondral samples (n ¼ 8) were prepared for friction
testing from the patellofemoral groove of skeletally mature bovine
stiﬂe joints, as described previously5,9. Samples were rinsed
vigorously overnight in phosphate buffered saline (PBS) to rid the
articular surface of residual SF5,9,10 prior to lubrication testing in
PBS. Samples were then bathed in the subsequent test lubricants,
completely immersing the cartilage surface, at 4C overnight prior
to the next day’s lubrication test. Samples were rinsed with PBS
after each test before incubation in the next test lubricant.
Lubrication test
A Bose ELF 3200 was used to analyse the boundary lubrication
ability of the PRG4 preparations, using a previously described
in vitro cartilage-on-cartilage friction test5,9. Brieﬂy, samples were
compressed at a constant rate of 0.002 mm/s to 18% of the total
cartilage thickness and were allowed 40 min to stress-relax to
enable ﬂuid depressurisation of the interstitial ﬂuid. The samples
were then rotatedþ2 then2 revolutions at an effective velocity of
0.3 mm/s (shown to maintain boundary mode lubrication at
a depressurised cartilageecartilage interface9) with pre-sliding
durations (Tps) of 1200, 120, 12 and 1.2 s. The test sequence was
then repeated in the opposite direction of rotation.
Experimental design
To determine the effect of aldehyde modiﬁcation on the carti-
lage boundary lubricating of PRG4, two test sequences were per-
formed. In both experiments, n ¼ 4 osteochondral samples were
tested sequentially in ﬁve test lubricants: PBS (negative control),
three PRG4-containing test lubricants, and then bovine SF (positive
control). Each PRG4-containing lubricant was prepared in PBS at
a physiological concentration of 450 mg/mL5.
Test Sequence 1 (n ¼ 4): PBS, PRG4-CHO, PRG4-SHAM, PRG4, SF
Test Sequence 2 (n ¼ 4): PBS, PRG4-SHAM, PRG4-CHO, PRG4, SF
Statistical analysis
Static (mstatic,Neq) and kinetic<mkinetic,Neq> friction coefﬁcients of
frictions, representing the resistance to start-up motion and steady
sliding motion respectively, were calculated as described previ-
ously5,9. Unless otherwise indicated, data is presented asmeanwith
a 95% conﬁdence interval (CI) (lower limit, upper limit). Analysis of
variance (ANOVA) was used to assess the effect of lubricant and Tps,
as a repeated factor, on mstatic,Neq and<mkinetic,Neq>, with Tukey posthoc testing on <mkinetic,Neq> at Tps ¼ 1.2 s. Statistical analysis was
implemented with Systat12 (Systat Software, Inc., Richmond, CA).
Results
Lubricant characterisation
PRG4-SHAM and PRG4-CHO had similar molecular weight
(MW) and reactivity to anti-PRG4 Abs LPN and J108N compared to
unmodiﬁed PRG4. Speciﬁcally, protein staining of NR PRG4, PRG4-
SHAM, and PRG4-CHO showed two high MW bands slightly
above (**) and below (*) the 460 kDa marker [Fig. 1(A)]. Upon
reduction, a single high MW band (**) was observed as well as
a predominant lower MW band w90 kDa (x) between the 71 kDa
and 117 kDa markers [Fig. 1(B)]. Western blotting of NR samples
showed two high MW (**, *) LPN-reactive bands [Fig. 1(C)] that co-
migrated with those observed by protein stain, while R samples
showed the high (**) and lower (x) J108N immunoreactive bands
[Fig. 1(D)] that co-migrated with those observed by protein stain.
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All PRG4 preparations functioned as effective friction-reducing
cartilage boundary lubricants. The order of testing (i.e., test
sequence 1 and 2) did not signiﬁcantly affect the friction coefﬁcient
values obtained for PRG4-SHAM and PRG4-CHO; PRG4-SHAM
<mkinetic,Neq> values at Tps ¼ 1.2 s from test sequence 1 vs test
sequence 2, P ¼ 0.554, and PRG4-CHO <mkinetic,Neq> values at
Tps¼ 1.2 s from test sequence 1 vs test sequence 2, P¼ 0.594, when
compared via ANOVA. Therefore, data was pooled for further anal-
ysis. Friction was dependent on lubricants and Tps. mstatic,Neq varied
with Tps and test lubricant (both P < 0.0001), with no interaction
(P¼ 0.216). Values increasedwith Tps andwere consistently highest
in PBS (ranging from 0.282 (0.223, 0.342) to 0.558 (0.453, 0.663))
and lowest in SF (ranging from 0.031 (0.026, 0.037) to 0.264 (0.207,
0.320)). Values in PRG4, PRG4-SHAM, and PRG4-CHO were inter-
mediate and appeared similar to each other, at earlier Tps [Fig. 2(A)].
<mkinetic,Neq> values exhibited similar trends, varyingwith lubricant
and Tps (both P < 0.0001), with no interaction (P ¼ 0.469),
increasing only slightly with Tps (values at Tps ¼ 1.2 s were within
176% (mean SD) of those at Tps¼ 1,200 s). Therefore, for brevity
and clarity, <mkinetic,Neq> data is presented at Tps ¼ 1.2 s only.
<mkinetic,Neq> values at Tps¼ 1.2 swere greatest in PBS (0.232 (0.180,
0.284)) and lowest in SF (0.025 (0.018, 0.032)). Values in PRG4 (0.101
(0.072, 0.130)), PRG4-SHAM (0.150 (0.127, 0.172)), and PRG4-CHO
(0.143 (0.124, 0.162)) were again similar and signiﬁcantly differentFig. 2. Static (mstatic,Neq) (A) and kinetic <mkinetic,Neq> at Tps ¼ 1.2 s (B) friction coef-
ﬁcients PRG4-SHAM, PRG4-CHO and PRG4 at 450 mg/mL. Sample size, n ¼ 8. (Differing
letters indicate signiﬁcant differences between groups).than PBS (PBS vs PRG4, P < 0.0001, PBS vs PRG4-SHAM, P ¼ 0.005;
PBS vs PRG4-CHO, P ¼ 0.002) and SF (SF vs PRG4, P ¼ 0.01; SF vs
PRG4-SHAM, P < 0.0001; SF vs PRG4-CHO, P < 0.0001), but not
statistically different from each other [PRG4 vs PRG4-SHAM,
P¼ 0.189; PRG4 vs PRG4-CHO, P¼ 0.324; PRG4-SHAMvsPRG4-CHO,
P ¼ 0.998, Fig. 2(B)].
Discussion
The SDS-PAGE western blotting and protein stain (Fig. 1) data
along with the lubrication test data (Fig. 2) indicate that CHO
modiﬁcation does not signiﬁcantly affect the protein structure or
lubricating function of PRG4. These results, togetherwith previously
published data demonstrating aldehyde modiﬁcation signiﬁcantly
enhances PRG4 adsorption to the surface of cartilage8, collectively
suggest PRG4-CHOmaybeuseful inmolecular resurfacing strategies
for tissue surfaces requiring lubrication.
The size distribution of species in PRG4, PRG4-SHAM and PRG4-
CHO appeared similar (Fig. 1). All preparations contained high MW
immunoreactive species, in addition to the previously observed
w90 kDa species released upon reduction11,12. Any potential effect
of the aldehyde modiﬁcation process on relative distribution of
different PRG4 structural forms, such as monomers and multi-
mers11, remain to be investigated. However, the maintenance of
lubrication function in PRG4-CHO preparations suggest higher
order structure was maintained, since reduction and alkylation of
PRG4 preparations has been shown to increase friction byw34%13.
Values of <mkinetic,Neq> values at Tps ¼ 1.2 s for PRG4-CHO/SHAM
appeared slightly increased compared to PRG4; however, these
apparent differenceswere not statistically signiﬁcant and the PRG4-
CHO/SHAM preparations effectively reduced friction compared to
PBS. A power of 0.92, at the 0.05 signiﬁcance level, was obtained
with the n ¼ 8 samples tested to detect a difference between the
values for PRG4 and PRG4-CHO. Values of mstatic,Neq in PRG4-CHO
appearing to be similar to those in PBS at long Tps (1,200 s) could
imply diminished in vivo lubricating function of PRG4-CHO in
situations of prolonged joint loading (standing); however, such
extrapolation of this in vitro data to in vivo situations is speculative.
The unmodiﬁed PRG4 used in this study was prepared from
skeletally mature bovine cartilage (in Calgary, AB) whereas PRG4-
CHO/SHAM was prepared from immature bovine cartilage (in
Evanston, IL); a potentially confounding factor. However, unmodi-
ﬁed immature PRG4 (obtained later) demonstrated equivalent
cartilage boundary lubricating ability to the unmodiﬁed PRG4 used
in the present study (<mkinetic,Neq> at 1.2 s: PBS 0.171 (0.108, 0.234),
mature bovine PRG4 0.066 (0.056, 0.076), calf PRG4 0.074 (0.061,
0.088), and SF 0.037 (0.035, 0.039) for n¼ 4). As such, the immature
and mature bovine PRG4 tested here possess similar lubrication
function, and protein structure (Fig.1), and provide the rationale for
their combined use of immature and mature PRG4. This result also
suggests development may not affect PRG4 structure and function,
although additional studies would be required to conﬁrm this
proposition, especially in humans.
While the mechanism of molecular interactions of PRG4 with
the cartilage surface remains to be elucidated, local administration
of recombinant human PRG4 in OA induced rat models has been
shown to have chondroprotective effects as well as reduce the
rate of cartilage degeneration and structural damage7. In addition,
recombinant PRG4 remained localised for up to 28 days following
a single injection intra-articular administration7. Given the fact that
aldehyde modiﬁcation enhances adsorption of PRG4 to the
cartilage surface, without altering lubrication function, future
in vivo studies could assess whether PRG4-CHO has an enhanced
ability to adhere and reside on joint tissues, and potentially provide
prolonged cartilage boundary lubricating function. Additionally,
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to unmodiﬁed PRG4, could be assessed as well. Lastly, PRG4
is known to act synergistically with hyaluronan (HA) as cartilage
boundary lubricants to reduce friction5,10. HA is a currently used
as biotherapeutic treatment for OA, which can provide pain-relief
for several months14, even though the retention time of the HA
solutions have been shown to be short14. While the mechanism
of molecular interactions of PRG4 and HA, whether in solution or
at a surface, also remains to be considered, future studies could
also assess whether PRG4-CHO maintains this synergistic rela-
tionship with HA and potentially enhance the efﬁcacy of such
treatments.
Lubricity is a desirable characteristic for many tissues, bio-
interfaces, and artiﬁcial surfaces. PRG4 is found on other tissue
surfaces other than articular cartilage, such as the pericardium,
pleural membrane, and recently the cornea epithelium and
conjunctiva3,15. Biomedical devices such as contact lenses and
artiﬁcial joint surfaces, as well as catheters and endoscopes, all
require low friction and wear at their interacting biointerfaces
where PRG4 may be benﬁcial8. Thus, aldehyde modiﬁcation could
potentially be used to coat a variety of biomaterials or tissue
surfaces with functional PRG4 and provide low-friction properties.
Furthermore, the chemical modiﬁcation strategies used here could
be applied to other lubricating molecules, either alone or in
combination with PRG4, for the biolubrication of other tissues,
biointerfaces, or non-biological materials.Author contributions
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